Anti Walker 256 carcinoma agent and combination thereof
US4328246A · kind A · utility
6Cited by
0References
3Claims
0Family size
Inventor
Key dates
| Filing date | Aug 20, 1980 |
| Grant date | May 4, 1982 |
| Priority date | — |
| Expiry date | Aug 20, 2000 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/215
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Clofibrate which lowers blood triglycerides has been found to be an affective anti Walker 256 carcinoma agent and when combined with hydrazine sulfate therapy the inhibition of growth of malignant Walker 256 carcinoma is outstanding.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.